GBA1 and Parkinson disease: Moreover, we found that quetiapine increased wild-type GCase protein levels and activity and partially ameliorated dopamine oxidation and α-synuclein accumulation in iPSC-derived dopaminergic neurons from patients with GBA1-linked and LRRK2-linked PD.